EDGAR Filing Documents for 0001047469-18-001496

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001047469-18-001496

Filing Date

2018-03-12

Accepted

2018-03-12 08:14:37

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2234798zs-3.htm	S-3	563569
2	EX-5.1	a2234798zex-5_1.htm	EX-5.1	76551
3	EX-5.2	a2234798zex-5_2.htm	EX-5.2	23940
4	EX-23.1	a2234798zex-23_1.htm	EX-23.1	3225
5	G21153.JPG	g21153.jpg	GRAPHIC	32052
	Complete submission text file	0001047469-18-001496.txt		712594

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: S-3 | Act: 33 | File No.: 333-223575 | Film No.: 18682117
SIC: 2834 Pharmaceutical Preparations